Framingham vascular age is associated with worse cognitive performance in the middle-aged and elderly.
View / Open Files
Authors
Badran, Abdul
Hollocks, Matthew J
Brookes, Rebecca L
Morris, Robin G
Markus, Hugh S
Publication Date
2019-07Journal Title
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn
ISSN
1382-5585
Publisher
Taylor & Francis
Volume
26
Issue
4
Pages
531-540
Language
English
Type
Article
This Version
AM
Metadata
Show full item recordCitation
Badran, A., Hollocks, M. J., Brookes, R. L., Morris, R. G., & Markus, H. S. (2019). Framingham vascular age is associated with worse cognitive performance in the middle-aged and elderly.. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, 26 (4), 531-540. https://doi.org/10.1080/13825585.2018.1499866
Abstract
"Normal" age-related cognitive decline has been associated with cardiovascular risk factors. Framingham Vascular Age is age-normed cardiovascular risk which may help communicate risk to patients and identify those at relatively higher risk. We aim to assess the association between Framingham Vascular Age and cognition. 346 "healthy" participants (57±10 years) without neuropsychiatric disorders or clinical manifestations of cardiovascular disease were studied. Cognition was evaluated using the Brief Memory and Executive Test and Framingham Vascular Age was calculated. The association between Framingham Vascular Age and cognitive performance was determined through General Linear Models to control for covariates. Framingham Vascular age was associated with poorer Memory and Executive Function/Processing Speed indices (p= 0.019 and p<0.001, respectively). We conclude Framingham Vascular Age is associated with worse Executive Function/Processing Speed and Memory. Vascular Age may help identify patients at higher risk of age-related cognitive decline with implications for communicating the morbidity associated with cardiovascular risk.
Keywords
Age-related cognitive decline, Framingham, brief memory and executive test, screening, vascular age
Sponsorship
This work was supported by the Stroke Association under Grant TSA 2010/08; British Heart Foundation under Grant PG/13/30/30005; and Stroke Association/British Heart Foundation Programme under Grant TSA BHF 2010/01. Hugh Markus is supported by a National Institute for Health Research Senior Investigator award and his work is supported by the Cambridge University Hospitals Trust National Institute for Health Research Comprehensive Biomedical Research Centre.
Funder references
Stroke Association (TSA 2010/08)
British Heart Foundation (None)
Identifiers
External DOI: https://doi.org/10.1080/13825585.2018.1499866
This record's URL: https://www.repository.cam.ac.uk/handle/1810/295468
Rights
Licence:
http://www.rioxx.net/licenses/all-rights-reserved
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk